BioCorRx Inc. (BICX)

BioCorRx Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	0.09	0.21	0.05	0.12	0.24
Revenue Growth (YoY)	-58.31%	342.99%	-60.63%	-48.96%	-36.21%
Cost of Revenue	0.24	0.02	0.01	0.1	0.08
Gross Profit	-0.15	0.2	0.04	0.03	0.16
Selling, General & Admin	2.7	3.41	3.74	3.17	4.57
Research & Development	0.89	1.46	1.61	4.27	1.13
Other Operating Expenses	0.01	-1.76	-0.77	-4.39	-1.06
Operating Expenses	3.59	3.11	4.58	3.05	4.63
Operating Income	-3.74	-2.91	-4.53	-3.03	-4.47
Interest Income	0	1.09	0.57	0.51	1.62
Interest Expense	0.89	1.09	0.57	0.51	1.62
Other Expense / Income	-0.86	1.47	0.68	0.48	1.58
Pretax Income	-3.77	-4.38	-5.21	-3.51	-6.05
Income Tax	-0	-0.01	0.59	0.51	1.66
Net Income	-3.77	-4.37	-5.8	-4.01	-7.71
Shares Outstanding (Basic)	8	7	6	5	4
Shares Outstanding (Diluted)	8	7	6	5	4
Shares Change	15.92%	10.90%	20.70%	52.64%	40.58%
EPS (Basic)	-0.45	-0.61	-0.89	-0.75	-2.19
EPS (Diluted)	-0.45	-0.61	-0.89	-0.75	-2.19
Free Cash Flow	-1.85	-2.04	-3.59	-2.16	-3.06
Free Cash Flow Per Share	-0.22	-0.28	-0.55	-0.40	-0.87
Gross Margin	-164.61%	92.85%	87.82%	21.75%	66.01%
Operating Margin	-4194.50%	-1360.12%	-9389.92%	-2468.87%	-1860.58%
Profit Margin	-4224.89%	-2043.30%	-12021.81%	-3274.31%	-3208.32%
Free Cash Flow Margin	-2078.60%	-954.81%	-7432.17%	-1762.42%	-1273.51%
EBITDA	-3.54	-2.95	-4.33	-2.83	-4.33
EBITDA Margin	-3970.26%	-1379.13%	-8979.39%	-2306.93%	-1801.18%
Depreciation & Amortization	0.2	0.14	0.17	0.17	0.1
EBIT	-3.74	-3.09	-4.5	-3	-4.42
EBIT Margin	-4194.50%	-1445.52%	-9329.37%	-2442.93%	-1841.34%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.